Trade GRDX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
GridAI Technologies Corp. (GRDX) is trading at US$2.86, down 3.70% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$25.27M. Over the past 52 weeks, GRDX has traded between US$1.87 and US$6.93. On Syfe you can trade GRDX with $0 commission and add it to your watchlist.
| Previous close | US$2.97 |
|---|---|
| Market cap | US$25.27M |
| 52-week range | US$1.87 – US$6.93 |
| Volume | 134.16K |
| Exchange | US |
Add to Watchlist
Set Price Alert
GridAI Technologies Corp.
GridAI Technologies Corp. is a diversified technology and life sciences company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Year: 2016
GridAI Technologies Corp. (GRDX) stock is trading at US$2.86, -3.70% from the previous close of US$2.97.
The market cap for GridAI Technologies Corp. (GRDX) stock is approximately US$25.27M.
The 52-week high for GridAI Technologies Corp. (GRDX) stock is US$6.93.
The 52-week low for GridAI Technologies Corp. (GRDX) stock is US$1.87.
GridAI Technologies Corp. (GRDX) does not currently pay a dividend.
Stay on top of GRDX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
